Eyas Al-Mousa
Overview
Explore the profile of Eyas Al-Mousa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hammoudeh A, Khader Y, Tabbalat R, Badaineh Y, Kadri N, Shawer H, et al.
Int J Vasc Med
. 2022 Apr;
2022:4240999.
PMID: 35462945
Background: Prevention of stroke and systemic embolism (SE) prevention in patients with atrial fibrillation (AF) has radically changed in recent years. Data on contemporary utilization of oral anticoagulants (OACs) and...
2.
Hammoudeh A, Khader Y, Kadri N, Al-Mousa E, Badaineh Y, Habahbeh L, et al.
Int J Vasc Med
. 2021 Apr;
2021:5515089.
PMID: 33898065
Background: There is a scarcity of studies that evaluate adherence to the utilization of guideline-recommended oral anticoagulant agents (OACs) in patients with atrial fibrillation (AF) in the Middle East. The...
3.
Hammoudeh A, Tabbalat R, Alhaddad I, Khader Y, Jarrah M, Izraiq M, et al.
Diabetol Int
. 2019 Jan;
8(1):30-38.
PMID: 30603304
Introduction: Diabetes mellitus (DM) is highly prevalent among Middle Eastern patients admitted with acute coronary syndrome (ACS) or who undergo percutaneous coronary intervention (PCI). This study used data from the...
4.
Reality of obesity paradox: Results of percutaneous coronary intervention in Middle Eastern patients
Jarrah M, Hammoudeh A, Khader Y, Tabbalat R, Al-Mousa E, Okkeh O, et al.
J Int Med Res
. 2018 Feb;
46(4):1595-1605.
PMID: 29468911
Objective The aim of this study was to assess the baseline clinical characteristics, coronary angiographic features, and adverse cardiovascular events during hospitalization and at 1 year of follow-up in obese...
5.
Hammoudeh A, Alhaddad I, Khader Y, Tabbalat R, Al-Mousa E, Saleh A, et al.
J Saudi Heart Assoc
. 2017 Jun;
29(3):195-202.
PMID: 28652673
Methods And Results: In this prospective, multicenter study, 2426 consecutive patients were enrolled. Mean age was 59.0 ± 10.1 years and 500 (20.6%) were women. Acute coronary syndrome and stable...
6.
Alhaddad I, Tabbalat R, Khader Y, Al-Mousa E, Izraiq M, Nammas A, et al.
Heart Views
. 2017 Jun;
18(1):3-7.
PMID: 28584584
Aim: This is a prospective multicenter registry designed to evaluate the incidence of adverse cardiovascular events in Middle Eastern patients undergoing percutaneous coronary interventions (PCI). The registry was also designed...
7.
Hammoudeh A, Izraiq M, Ismail Y, Tabbalat R, El-Harassis A, Al-Tarawneh H, et al.
Int J Cardiol
. 2007 Feb;
122(2):156-7.
PMID: 17321618
No abstract available.
8.
Hammoudeh A, Al-Tarawneh H, Elharassis A, Haddad J, Mahadeen Z, Badran N, et al.
Int J Cardiol
. 2005 Oct;
110(2):179-83.
PMID: 16233922
Background: The prevalence of the major conventional cardiovascular risk factors - cigarette smoking, diabetes mellitus, hypertension, and dyslipidemia - among coronary heart disease (CHD) patients in the Middle East has...